Literature DB >> 27666677

Markers of oxidative stress in obese men with and without hypertension.

Vanja Cejvanovic1,2, Camilla Asferg3,4, Laura Kofoed Kjær1, Ulrik B Andersen4, Allan Linneberg2,5,6, Jan Frystyk7,8, Trine Henriksen1, Allan Flyvbjerg7,8, Michael Christiansen9,10, Allan Weimann1, Jørgen Jeppesen2,3, Henrik Enghusen Poulsen1,2.   

Abstract

OBJECTIVES: The aim of our study was to investigate if the 24-hour excretion of the urinary markers for oxidative stress to DNA and RNA, measured as 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydro-guanosine (8-oxoGuo), respectively, were increased in obese individuals with or without hypertension compared to lean controls.
METHODS: A total of 63 obese hypertensive men (obeseHT), 40 obese normotensive men (obeseNT) and 27 lean normotensive men (leanNT) were included in the study. Body mass index (BMI) was between 20.0 and 24.9 kg/m2 in leanNT participants and ≥30 kg/m2 in obese participants. Hypertension was defined as a mean 24-hour systolic ambulatory blood pressure (AMBP) ≥ 130 mmHg or a mean 24-hour diastolic AMBP ≥80 mmHg and normotension as mean 24-hour AMBP <130/80 mmHg. Twenty-four hour urinary 8-oxoGuo and 8-oxodG excretion (nmol/24 h) were measured by a validated liquid chromatography-tandem mass spectrometry method (UPLC-MS/MS).
RESULTS: Urinary 8-oxoGuo excretion was (median and [interquartile range]) 30.8 [27.8-32.2] nmol/24 h in leanNT, 36.8 [31.3-40.2] nmol/24 h in obeseNT and 40.6 [31.7-48.5] nmol/24 h in obeseHT. The difference was statistically significant (p = .002) and post hoc tests showed a significant difference between leanNT and obeseHT (p = .001) as well as obeseNT (p = .002), whereas the two obese groups did not differ (p = .6). No statistically significant differences in 8-oxodG concentrations were observed between the three groups (p = .3).
CONCLUSION: The measurement of urinary excretion of 8-oxoGuo suggests that obesity in men, but not hypertension, is associated with increased oxidative damage to RNA.

Entities:  

Keywords:  8-oxo-7,8-dihydro-2'-deoxyguanosine; 8-oxo-7,8-dihydroguanosine; hypertension; obesity; oxidative stress; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27666677     DOI: 10.1080/00365513.2016.1230776

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

1.  Urinary Oxidative Damage Markers and Their Association with Obesity-Related Metabolic Risk Factors.

Authors:  Salah Gariballa; Abderrahim Nemmar; Ozaz Elzaki; Nur Elena Zaaba; Javed Yasin
Journal:  Antioxidants (Basel)       Date:  2022-04-26

Review 2.  Redox changes in obesity, metabolic syndrome, and diabetes.

Authors:  Bato Korac; Andjelika Kalezic; Vanja Pekovic-Vaughan; Aleksandra Korac; Aleksandra Jankovic
Journal:  Redox Biol       Date:  2021-02-04       Impact factor: 11.799

3.  Increased Oxidative Stress Underlies Abnormal Pain Threshold in a Normoglycemic Japanese Population.

Authors:  Sho Osonoi; Hiroki Mizukami; Chieko Itabashi; Kanichiro Wada; Kazuhiro Kudoh; Akiko Igawa; Saori Ogasawara; Yasuyuki Ishibashi; Makoto Daimon; Soroku Yagihashi; Shigeyuki Nakaji
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

4.  Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery-An observational cohort study of changes in urinary markers.

Authors:  Elin Rebecka Carlsson; Mogens Fenger; Trine Henriksen; Laura Kofoed Kjaer; Dorte Worm; Dorte Lindqvist Hansen; Sten Madsbad; Henrik Enghusen Poulsen
Journal:  PLoS One       Date:  2020-12-14       Impact factor: 3.240

5.  Effects of 2-Year Nutritional and Lifestyle Intervention on Oxidative and Inflammatory Statuses in Individuals of 55 Years of Age and over at High Cardiovascular Risk.

Authors:  Margalida Monserrat-Mesquida; Magdalena Quetglas-Llabrés; Cristina Bouzas; Silvia García; David Mateos; Cristina Gómez; José M Gámez; Henrik E Poulsen; Josep A Tur; Antoni Sureda
Journal:  Antioxidants (Basel)       Date:  2022-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.